Biophytis - ADR
BPTS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.61M
Close$
$-0.01
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.61 Million |
|---|---|
| Enterprise Value | $10.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-12.55 |
| Beta | 1.05 |
| Outstanding Shares | 3,499,000 |
Return
| Return on Equity | 357.68% |
|---|---|
| Return on Assets | -262.08% |
| Return on Invested Capital | 377.24% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | -4.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | -1.52 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biophytis
2,020 employees
CEO: Stanislas Veillet